Johnson & Johnson

NYSE: JNJ · Real-Time Price · USD
177.53
1.28 (0.73%)
At close: Aug 19, 2025, 1:55 PM

Johnson & Johnson Income Statement

Financials in USD. Fiscal year is February - January.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 29, 2025 Mar 30, 2025 Dec 29, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Jan 1, 2023 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Jan 2, 2022 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Revenue
23.74B 21.89B 22.52B 22.47B 22.45B 21.38B 21.39B 21.35B 21.52B 20.89B 23.71B 20B 24.02B 23.43B 24.8B 23.34B 23.31B 22.32B
Cost of Revenue
7.63B 7.36B 7.13B 6.96B 6.87B 6.51B 6.8B 6.61B 6.46B 6.69B 7.76B 6.17B 7.92B 7.6B 7.96B 7.25B 7.59B 7.06B
Gross Profit
16.11B 14.54B 15.39B 15.51B 15.58B 14.87B 14.6B 14.74B 15.06B 14.21B 15.94B 13.82B 16.1B 15.83B 16.85B 16.09B 15.72B 15.26B
Operating Income
6.71B 6.3B 3.84B 5.28B 6.66B 6.27B 4.61B 6.2B 6.36B 6.25B 3.9B 5.66B 6.47B 6.12B 4.47B 6.87B 6.36B 6.85B
Interest Income
n/a 332M 281M 292M 395M 364M 363M 374M 326M 198M 254M 150M 64M 22M 13M 13M 12M 15M
Pretax Income
6.49B 13.63B 3.89B 3.34B 5.75B 3.71B 4.83B 5.22B 6.31B -1.29B 4.2B 5.17B 5.84B 5.86B 4.84B 3.85B 6.66B 7.43B
Net Income
5.54B 11B 3.43B 2.69B 4.69B 3.25B 4.05B 26.03B 5.14B -68M 3.52B 4.46B 4.81B 5.15B 4.74B 3.67B 6.28B 6.2B
Selling & General & Admin
5.89B 5.01B 6.25B 5.28B 5.48B 5.06B 5.51B 5.1B 5B 4.51B 7.41B 4.67B 5.93B 5.64B 7.65B 5.8B 5.97B 5.23B
Research & Development
3.52B 3.23B 5.3B 4.95B 3.44B 3.54B 4.48B 3.45B 3.7B 3.46B 4.62B 3.48B 3.7B 4.07B 4.72B 3.42B 3.39B 3.18B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
9.4B 8.24B 11.55B 10.23B 8.92B 8.6B 9.99B 8.55B 8.7B 7.96B 12.04B 8.16B 9.63B 9.71B 12.37B 9.22B 9.37B 8.41B
Interest Expense
48M 204M 137M 193M 270M 155M 151M 192M 217M 212M 177M 51M 38M 10M 60M 20M 40M 63M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.03B 15.59B 18.68B 17.19B 15.79B 15.11B 16.79B 15.15B 15.16B 14.65B 19.8B 14.33B 17.55B 17.31B 20.33B 16.47B 16.95B 15.47B
Income Tax Expense
954M 2.63B 456M 644M 1.06B 459M 694M 908M 930M -796M 681M 862M 1.03B 713M 100M 182M 384M 1.23B
Shares Outstanding (Basic)
2.42B 2.41B 2.41B 2.41B 2.41B 2.41B 2.41B 2.52B 2.6B 2.61B 2.61B 2.62B 2.63B 2.63B 2.63B 2.63B 2.63B 2.63B
Shares Outstanding (Diluted)
2.42B 2.42B 2.43B 2.43B 2.42B 2.43B 2.43B 2.55B 2.63B 2.61B 2.66B 2.66B 2.67B 2.67B 2.67B 2.67B 2.67B 2.67B
EPS (Basic)
2.29 4.57 1.43 1.12 1.95 1.35 1.68 10.32 1.98 -0.03 1.35 1.70 1.83 1.96 1.80 1.39 2.38 2.35
EPS (Diluted)
2.29 4.54 1.41 1.11 1.93 1.34 1.67 10.21 1.96 -0.03 1.33 1.68 1.80 1.93 1.77 1.37 2.35 2.32
EBITDA
6.49B 15.61B 5.92B 5.38B 7.8B 5.68B 6.82B 7.24B 8.46B 805M 6.15B 6.91B 7.62B 7.64B 6.74B 5.68B 8.54B 9.39B
EBIT
6.49B 13.84B 4.02B 3.53B 6.02B 3.87B 4.98B 5.41B 6.52B -1.07B 4.38B 5.22B 5.88B 5.87B 4.9B 3.87B 6.7B 7.49B
Depreciation & Amortization
n/a 1.77B 1.9B 1.85B 1.78B 1.81B 1.84B 1.83B 1.93B 1.88B 1.77B 1.69B 1.74B 1.77B 1.84B 1.81B 1.84B 1.89B